| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3435332 | American Journal of Obstetrics and Gynecology | 2010 | 6 Pages |
Abstract
EGCG prevented hyperglycemia-induced embryopathy through inhibition of Forkhead transcription factor 3a activation. This may have been mediated via the activation of Akt. These findings offer the potential for a possible pharmacological prophylaxis for hyperglycemia-induced embryonic malformations.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Peixin PhD, Hua BS,